Register entry
- Registered sites
- 0
- Active NDC listings
- 6
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
66 active NDC listings: 6 human otc drug. By marketing category: ANDA 6.
| Dosage form | NDCs |
|---|---|
| tablet | 6 |
| Route | NDCs |
|---|---|
| oral | 6 |
| Labeller name on the listing | NDCs |
|---|---|
| rapha pharmaceuticals, inc. | 6 |
Catalogue
Marketed products
6| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Morning After | Levonorgestrel | tablet, oral | 69953-515ANDA |
| Morning After | Levonorgestrel | tablet, oral | 69953-516ANDA |
| Morning After | Levonorgestrel | tablet, oral | 69953-517ANDA |
| PostDay One-Step | Levonorgestrel | tablet, oral | 69953-617ANDA |
| PostDay One-Step | Levonorgestrel | tablet, oral | 69953-618ANDA |
| PostDay One-Step | Levonorgestrel | tablet, oral | 69953-628ANDA |
Compare
Other companies listing levonorgestrel
- Lupin Limited14 sites · 506 NDC
- Bayer Healthcare Manufacturing Srl13 sites · 360 NDC
- Glenmark Pharmaceuticals Inc., USA9 sites · 383 NDC
- Curia India Private Limited9 sites · 106 NDC
- CIPLA PHARMACEUTICALS LIMITED7 sites · 368 NDC
- Allergan, Inc.7 sites · 187 NDC
- P & L Development, LLC5 sites · 119 NDC
- Gedeon Richter Plc.3 sites · 11 NDC
- Symbiotec Pharmalab Limited2 sites · 53 NDC
- OHM PHARMA INC.1 site · 155 NDC
Enquiry
Common questions
- Is Rapha Pharmaceuticals, Inc. FDA approved?
- Rapha Pharmaceuticals, Inc. holds no registered establishment of its own; 6 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Rapha Pharmaceuticals, Inc. make?
- 6 products are listed under Rapha Pharmaceuticals, Inc. in the openFDA NDC Directory, most often as tablet. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.